| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-10 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0002 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0005 |